These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7065626)

  • 41. [Value of isosorbide dinitrate injection in the acute phase of myocardial infarction. Clinical and haemodynamic study (author's transl)].
    Denis B; Pellet J; Machecourt J; Wolf JE; Dimitriou R; Bouvagnet P
    Nouv Presse Med; 1982 Jun; 11(27):2075-7. PubMed ID: 7110968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete atrioventricular block after sublingual isosorbide dinitrate.
    Antonelli D; Barzilay J
    Int J Cardiol; 1986 Jan; 10(1):71-3. PubMed ID: 3510989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Proceedings: Oral nitroglycerin preparations in the therapy of left heart failure in acute myocardial infarct].
    Bussmann WD; Löhner J; Kaltenbach M
    Z Kardiol; 1974; 0(Suppl 1):52. PubMed ID: 4215254
    [No Abstract]   [Full Text] [Related]  

  • 44. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frusemide or isosorbide dinitrate for acute heart failure?
    Lancet; 1983 May; 1(8333):1108-9. PubMed ID: 6133141
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug regimens for congestive heart failure.
    Unverferth DV; Magorien RD; Leier CV
    Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
    [No Abstract]   [Full Text] [Related]  

  • 47. [The effect of isosorbide dinitrate-VUFB using right-sided heart catheterization].
    Kohout P; Sochor K; Bufka V; Sova Z
    Cas Lek Cesk; 1986 Sep; 125(38-39):1204-7. PubMed ID: 3779769
    [No Abstract]   [Full Text] [Related]  

  • 48. [Oral administration of isosorbide dinitrate in myocardial infarction without heart insufficiency. Its hemodynamic effects].
    Dereume G; Culotta A; Bernard R
    Rev Med Interne; 1981; 2(1):121-9. PubMed ID: 7232920
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis and management of chronic heart failure.
    Aguiar-Souto P; Garcia-Pavia P; Silva-Melchor L; Ortigosa FJ
    J Am Coll Cardiol; 2006 Jul; 48(1):223; author reply 224. PubMed ID: 16814680
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic range of transdermal nitro-patches].
    Lazebnik LB
    Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
    [No Abstract]   [Full Text] [Related]  

  • 51. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Suppression of complex ventricular arrhythmias with isosorbide dinitrate in a case of congestive heart failure].
    Gnecchi M; De Marzio P; Morelli S; Aguglia F
    Cardiologia; 1985 May; 30(5):401-4. PubMed ID: 3833353
    [No Abstract]   [Full Text] [Related]  

  • 55. [Letter: The acute pulmonary edema of ischemic cardiopathies. Emergency treatment by administration per os of a nitro derivative].
    Chiche P; Baligadoo S
    Nouv Presse Med; 1975 Sep; 4(30):2198-9. PubMed ID: 1101208
    [No Abstract]   [Full Text] [Related]  

  • 56. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites.
    Pimlott SJ; Addy M
    Oral Surg Oral Med Oral Pathol; 1985 Feb; 59(2):145-8. PubMed ID: 3856798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative studies of the dissolution kinetics of 2 pharmaceutical forms of isosorbide dinitrate for sublingual administration: capsules and tablets].
    Rabasco AM; Ortega M; Faulí C
    Farmaco Prat; 1984 May; 39(5):158-69. PubMed ID: 6734800
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of intravenous dinitrate injection on hemodynamics in dogs with experimental ventricular septal defects].
    Nakatsu T; Tomimatsu H; Sato N; Matsuoka S; Ueta H; Miyao M; Yuasa Y
    Kokyu To Junkan; 1983 Oct; 31(10):1111-5. PubMed ID: 6665330
    [No Abstract]   [Full Text] [Related]  

  • 59. [Polygraphic examination of patients with ischemic heart disease after administration of Viskenit 45 (author's transl)].
    Stríz S; Cagán S; Kocinger A
    Bratisl Lek Listy; 1981 Jan; 75(1):58-68. PubMed ID: 7214172
    [No Abstract]   [Full Text] [Related]  

  • 60. Complete atrioventricular block due to sublingual isosorbide dinitrate.
    Viskin S; Heller K; Porat R; Belhassen B
    South Med J; 1991 Mar; 84(3):369-70. PubMed ID: 2000524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.